2-year safety and efficacy results for benralizumab

被引：4
|
作者：
Chung, Kian Fan [1 ,2 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, Fac Med, London SW3 6LY, England
[2] Royal Brompton & Harefield NHS Fdn Trust, Resp Unit, London, England
来源：
LANCET RESPIRATORY MEDICINE | 2019年 / 7卷 / 01期
关键词：
SEVERE ASTHMA;
D O I：
10.1016/S2213-2600(18)30468-5
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：5 / 6
页数：3
相关论文
共 50 条
  • [41] Efficacy and safety of treatment with benralizumab for eosinophilic asthma
    Zhu, Miaojuan
    Yang, Jiong
    Chen, Yifei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 111
  • [42] Safety profile of once-monthly oral ibandronate: MOBILE 2-year results
    Bolognese, M
    Luckey, M
    Miller, P
    Civitelli, R
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 793 - 793
  • [43] 2-YEAR RESULTS OF TELBIVUDINE (LDT) ROADMAP STUDY VERIFY THE OPTIMAL EFFICACY AND SAFETY RESULTS IN HBEAG POSITIVE CHRONIC HEPATITIS B (CHB) PATIENTS
    Piratvisuth, T.
    Komolmit, P.
    Tanwandee, T.
    Sukeepaisarnjaroen, W.
    Chan, H. L.
    Pessoa, M. G.
    Fassio, E.
    Ono-Nita, S.
    Bessone, F.
    Daruich, J.
    Zeuzem, S.
    Cheinquer, H.
    Dong, Y.
    Trylesinski, A.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S214 - S214
  • [44] Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study
    Johann D. Ringe
    Parvis Farahmand
    Herbert Faber
    Alfred Dorst
    Rheumatology International, 2009, 29 : 311 - 315
  • [45] Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study
    Ringe, Johann D.
    Farahmand, Parvis
    Faber, Herbert
    Dorst, Alfred
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (03) : 311 - 315
  • [46] Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: A 2-YEAR study
    Tamas, Fischer
    ORVOSI HETILAP, 2015, 156 (49) : 2013 - 2013
  • [47] Efficacy and safety of acarbose in the treatment of Type 2 diabetes: data from a 2-year surveillance study
    Mertes, G
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 40 (01) : 63 - 70
  • [48] Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study
    Del Prato, S.
    Camisasca, R.
    Wilson, C.
    Fleck, P.
    DIABETES OBESITY & METABOLISM, 2014, 16 (12): : 1239 - 1246
  • [49] Long-term efficacy and safety of adalimumab in the treatment of active ankylosing spondylitis: Results of an open-label, 2-year trial
    Haibel, H.
    Brandt, H. C.
    Baraliakos, X.
    Rudwaleit, M.
    Listing, J.
    Braun, J.
    Kupper, H.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 218 - 219
  • [50] Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
    Santos, Raul D.
    Duell, P. Barton
    East, Cara
    Guyton, John R.
    Moriarty, Patrick M.
    Chin, Wai
    Mittleman, Robert S.
    EUROPEAN HEART JOURNAL, 2015, 36 (09) : 566 - 575
12345